Trial · NCT02883556
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Response rate (RR) | 15 weeks | Response rate (RR) at 15 weeks (RECIST v.1.1) in the whole sample by CT or MRI Response Evaluation Criteria in Solid Tumors with central radiology review |
| Secondary | Safety profile (NCI CTCAE v4.0) | up to 28 months | Advers event and serious adverse event status |
| Secondary | RR in PD-L1-positive patients | 15 weeks | To assess in the whole sample and in PD-L1 positive patients |
| Secondary | Disease Control Rate using RECIST and modified RECIST v.1.1 | 15 weeks | Controled by the radiological evaluation |
| Secondary | RR using modified RECIST 1.1 | 15 weeks | Controled by the radiological evaluation |
| Secondary | RR using RECIST and modified RECIST v.1.1 | 24 weeks | Controled by the radiological evaluation |
| Secondary | Best RR using RECIST and modified RECIST v.1.1 | 24 months | The best response was collected after all radiological evaluation completion |
| Secondary | Overall Survival (OS) | up to 24 months | Survival status |
| Secondary | Progression Free Survival by RECIST 1.1 and modified RECIST 1.1 | up to 24 months | Controled by the radiological evaluation |
| Secondary | Duration of response (DOR) by RECIST 1.1 and modified RECIST 1.1 | up to 24 months | Controled by the radiological evaluation |
| Secondary | Duration of control by RECIST 1.1 and modified RECIST 1.1 | up to 24 months | Controled by the radiological evaluation |
| Secondary | Time to disease progression by RECIST 1.1 and modified RECIST 1.1 | up to 24 months | Controled by the radiological evaluation |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02883556/registered